Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients

MLA

Alhaji H. Janneh, et al. “Alterations of Lipid Metabolism Provide Serologic Biomarkers for the Detection of Asymptomatic versus Symptomatic COVID-19 Patients.” Scientific Reports, vol. 11, no. 1, July 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41598-021-93857-7.

APA

Alhaji H. Janneh, Mohamed Faisal Kassir, Connor J. Dwyer, Paramita Chakraborty, Jason S. Pierce, Patrick A. Flume, Hong Li, Satish N. Nadig, Shikhar Mehrotra, & Besim Ogretmen. (2021). Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients. Scientific Reports, 11(1), 1–10. https://doi.org/10.1038/s41598-021-93857-7

Chicago

Alhaji H. Janneh, Mohamed Faisal Kassir, Connor J. Dwyer, Paramita Chakraborty, Jason S. Pierce, Patrick A. Flume, Hong Li, Satish N. Nadig, Shikhar Mehrotra, and Besim Ogretmen. 2021. “Alterations of Lipid Metabolism Provide Serologic Biomarkers for the Detection of Asymptomatic versus Symptomatic COVID-19 Patients.” Scientific Reports 11 (1): 1–10. doi:10.1038/s41598-021-93857-7.